• Profile
Close

Metabolic syndrome and the incidence of hepatocellular carcinoma: A meta-analysis of cohort studies

OncoTargets and Therapy Oct 04, 2018

Chen Y, et al. - An updated meta-analysis was conducted to assess if metabolic syndrome (MetS) influenced the incidence of hepatocellular carcinoma (HCC). By searching PubMed and Embase databases, relevant cohort studies were identified. An association was found between the presence of MetS and a higher incidence of HCC in males, but not females. Regardless of whether alcohol intake was adjusted, the relationship between MetS and a higher risk of HCC was consistent. Findings revealed that MetS conferred a higher risk of HCC in carriers of hepatitis B virus vs the general population, although both were significant.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay